15% of myasthenia gravis (MG) patients do not have antibodies against the acetylcholine receptor (AChR). Some of these "seronegative" MG patients have antibodies against muscle specific kinase (MuSK), and many have a non-IgG factor that acutely inhibits AChR function in a muscle-like cell line, CN21. Here we show, using mainly one plasma negative for both AChR and MuSK antibodies, that the inhibitory effect of the non-IgG fraction correlates well with the desensitisation caused by 100 microM nicotine, and is found also when AChRs are expressed in a non-muscle cell line (HEK). Moreover, a similar effect was seen with M3C7-a monoclonal antibody against human AChR. The results suggest that, rather than acting indirectly as previously proposed,...
A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to mus...
A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to mus...
Myasthenia gravis (MG) is a prototype Ab-mediated autoimmune disease in which Abs against nicotinic ...
A proportion of patients with myasthenia gravis (MG) do not have antibodies to the acetylcholine rec...
Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junction. In ...
Antibodies to muscle-specific kinase (MuSK) are found in a variable proportion of patients with myas...
BACKGROUND: Approximately 10% to 20% of patients with autoimmune MG do not have antibodies to the ac...
Only around 80 % of patients with generalized myasthenia gravis (MG) have serum antibodies to acetyl...
Muscle-specific tyrosine kinase (MuSK) antibodies are found in some patients with "seronegative" mya...
Only around 80% of patients with generalized myasthenia gravis (MG) have serum antibodies to acetylc...
Only around 80% of patients with generalized myasthenia gravis (MG) have serum antibodies to acetylc...
Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction (NMJ). Most patients...
Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies that are either directed t...
Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies that are either directed t...
Acetylcholine receptor (AChR) antibodies are present in around 85% of patients with myasthenia gravi...
A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to mus...
A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to mus...
Myasthenia gravis (MG) is a prototype Ab-mediated autoimmune disease in which Abs against nicotinic ...
A proportion of patients with myasthenia gravis (MG) do not have antibodies to the acetylcholine rec...
Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junction. In ...
Antibodies to muscle-specific kinase (MuSK) are found in a variable proportion of patients with myas...
BACKGROUND: Approximately 10% to 20% of patients with autoimmune MG do not have antibodies to the ac...
Only around 80 % of patients with generalized myasthenia gravis (MG) have serum antibodies to acetyl...
Muscle-specific tyrosine kinase (MuSK) antibodies are found in some patients with "seronegative" mya...
Only around 80% of patients with generalized myasthenia gravis (MG) have serum antibodies to acetylc...
Only around 80% of patients with generalized myasthenia gravis (MG) have serum antibodies to acetylc...
Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction (NMJ). Most patients...
Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies that are either directed t...
Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies that are either directed t...
Acetylcholine receptor (AChR) antibodies are present in around 85% of patients with myasthenia gravi...
A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to mus...
A variable proportion of patients with generalized myasthenia gravis (MG) have autoantibodies to mus...
Myasthenia gravis (MG) is a prototype Ab-mediated autoimmune disease in which Abs against nicotinic ...